CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | O'Sullivan Miriam SVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +11,143 | 11,143 | ||
| 2026-02-12 | Woodworth Emily SVP, Global Controller and CAO | Option exercise | +481 | 1,193 | ||
| 2026-02-12 | Woodworth Emily SVP, Global Controller and CAO | Shares withheld for taxes | −242 | $74.12 | $18K | 951 |
| 2026-02-12 | Woodworth Emily SVP, Global Controller and CAO | Option exercise · Restricted Stock Units | −481 | 962 | ||
| 2026-02-12 | Woodworth Emily SVP, Global Controller and CAO | Grant or award · Restricted Stock Units | +6,071 | 6,071 | ||
| 2026-02-12 | Woodworth Emily SVP, Global Controller and CAO | Grant or award · Stock Option (Right to Buy) | +5,584 | 5,584 | ||
| 2026-02-12 | O'Connor Padraig Andrew EVP, Global Operations | Option exercise | +1,058 | 4,943 | ||
| 2026-02-12 | O'Connor Padraig Andrew EVP, Global Operations | Shares withheld for taxes | −457 | $74.12 | $34K | 4,486 |
| 2026-02-12 | O'Connor Padraig Andrew EVP, Global Operations | Option exercise · Restricted Stock Units | −1,058 | 2,116 | ||
| 2026-02-12 | O'Connor Padraig Andrew EVP, Global Operations | Grant or award · Restricted Stock Units | +5,059 | 5,059 | ||
| 2026-02-12 | O'Connor Padraig Andrew EVP, Global Operations | Grant or award · Stock Option (Right to Buy) | +11,939 | 11,939 | ||
| 2026-02-12 | Monson Jonathan EVP and CFO | Option exercise | +1,154 | 36,443 | ||
| 2026-02-12 | Monson Jonathan EVP and CFO | Shares withheld for taxes | −573 | $74.12 | $42K | 35,870 |
| 2026-02-12 | Monson Jonathan EVP and CFO | Option exercise · Restricted Stock Units | −1,154 | 2,308 | ||
| 2026-02-12 | Monson Jonathan EVP and CFO | Grant or award · Restricted Stock Units | +11,805 | 11,805 | ||
| 2026-02-12 | Monson Jonathan EVP and CFO | Grant or award · Stock Option (Right to Buy) | +27,857 | 27,857 | ||
| 2026-02-12 | Mahoney Michael F Chairman, President & CEO | Option exercise | +13,704 | 1,425,439 | ||
| 2026-02-12 | Mahoney Michael F Chairman, President & CEO | Shares withheld for taxes | −6,626 | $74.12 | $491K | 1,418,813 |
| 2026-02-12 | Mahoney Michael F Chairman, President & CEO | Option exercise · Restricted Stock Units | −13,704 | 27,408 | ||
| 2026-02-12 | Mahoney Michael F Chairman, President & CEO | Grant or award · Restricted Stock Units | +55,652 | 55,652 |
Page 8 of 40 · 791 trades